Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Virus Diagnosis Device Delivers Lab-Quality Results within Three Minutes

By LabMedica International staff writers
Posted on 03 Nov 2023

Researchers have developed a device capable of delivering lab-grade viral diagnostic results in just three minutes, offering a rapid and economical solution for detecting COVID-19 from nasal swabs. More...

This technology, according to its developers, is versatile enough to be modified for identifying various pathogens, such as bacteria, and potentially even cancer.

The prototype LoCKAmp device developed by engineers at the University of Bath (Bath, UK) uses advanced 'lab on a chip' technology. The device operates by quickly releasing and amplifying genetic material from a nasal swab sample and facilitating a chemical reaction that produces a result that can be viewed through a smartphone application. The LoCKAmp device differs from the common lateral flow tests used throughout the pandemic by employing the same genetic detection methods previously reserved for laboratory-grade PCR (polymerase chain reaction) tests, delivering rapid lab-level testing to the public for the first time. A key feature of the LoCKAmp is its rapid result time, clocking in at three minutes, making it the fastest COVID-19 test reported so far.

Built using readily available parts and mass-produced circuit boards, the LoCKAmp prototype device can be manufactured quickly and cost-effectively on a large scale. This presents an efficient new tool for healthcare providers and public health authorities globally in the field of virus detection. The research team suggests that with a commercial partner experienced in design and manufacturing, the LoCKAmp could be redesigned into a compact, portable device, ideal for use in areas with limited access to healthcare. Beyond just evaluating nasal swab samples, the LoCKAmp technology also has the potential for anonymous, community-level virus monitoring by testing samples from sources such as wastewater.

“This is an amazing display of the possibilities of lab-on-a-chip technology, and given the low cost and adaptability of the technology to detect a range of conditions, a potentially highly valuable and unique tool for a range of healthcare settings,” said Dr. Despina Moschou from the University of Bath who led the research.

Related Links:
University of Bath


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.